Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials
From MaRDI portal
Publication:1654244
DOI10.1016/j.csda.2017.02.009zbMath1464.62016OpenAlexW2590308184MaRDI QIDQ1654244
Barbara Bogacka, D. Stephen Coad, M. Iftakhar Alam
Publication date: 7 August 2018
Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)
Full work available at URL: http://qmro.qmul.ac.uk/xmlui/handle/123456789/22491
continuation ratio modelpopulation pharmacokinetics\(D\)-optimum sampling timesarea under the concentration curveone-compartment pharmacokinetic model
Computational methods for problems pertaining to statistics (62-08) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Dose-Finding Based on Efficacy-Toxicity Trade-Offs
- Model-oriented design of experiments
- Dose finding in drug development.
- Adaptive designs for dose-finding based on efficacy-toxicity response
- Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
- Optimal design in random-effects regression models
- Mixed-Effects Models in S and S-PLUS
- A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
- Bayesian Analysis of Linear and Non-Linear Population Models by Using the Gibbs Sampler
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers